Tag Archives: Cellectis

Cell-based Immunotherapies in the News

Baxalta, the biopharmaceutical spinoff of Baxter, entered into a $1.7 B deal with Precision BioSceinces for 6 CAR-T (Chimeric Antigen Receptor T-cell) projects, and Saronic Biotechnology announced positive data in preclinical studies of its autologous dendritic cell vaccine for hepatocellular carcinoma. Continue reading

Gene-edited donor T-cells save baby with incurable leukemia

An experimental therapy made of genetically-modified donor T-cells cured a baby with incurable leukemia: Continue reading